Study Identifies D-Retro-Inverso Peptides as Potential Treatments for Cardiac Amyloidosis
Scientists have used computational molecular dynamics simulations to identify two peptide candidates, DRI-R5S and DRI-H6A, that may disrupt the formation of Serum Amyloid A (SAA) fibrils linked to post-heart attack complications. The study builds on a hypothesis that SAA protein aggregates form in the heart after myocardial infarction and contribute to long-term cardiac damage, a mechanism potentially shared between mice and humans. If validated experimentally, these drug candidates could represent a new therapeutic approach to reducing cardiac amyloidosis following heart attacks.
A new preprint study published on bioRxiv proposes four D-retro-inverso (DRI) peptide candidates designed to interfere with the aggregation of Serum Amyloid A 3 (SAA3) fibrils, which are hypothesized to contribute to long-term complications after myocardial infarction. The research was motivated by prior mouse model findings suggesting that SAA aggregates form in cardiac tissue following a heart attack, with researchers proposing a similar mechanism may occur in humans. Using all-atom molecular dynamics simulations, the team computationally evaluated each peptide's ability to destabilize existing SAA fibrils. Two candidates — DRI-R5S and DRI-H6A — were identified as the most promising. The peptides are constructed from D-amino acids, the mirror-image form of the L-amino acids found in natural proteins, a design strategy intended to increase drug longevity by making them more resistant to enzymatic degradation. The study is entirely computational at this stage and has not yet been validated through laboratory or clinical experiments.
What's missing
The study relies solely on computational simulations and has not been tested in cell cultures, animal models, or human trials, leaving efficacy and safety entirely unestablished. Additionally, as a bioRxiv preprint, this work has not yet undergone formal peer review.
What different sources said
- bioRxivCenter
D-Retro-Inverso Peptide Candidates for Inhibiting SAA Cardiac Amyloidosis
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.